Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 Healthcare Stocks That Are Too Cheap to Ignore
10:52am, Thursday, 09'th Feb 2023 The Motley Fool
Pay attention when stocks have these kinds of low valuations.
Pandemic Profits In Healthcare
04:26am, Thursday, 09'th Feb 2023
Pfizer and Moderna profited by developing vaccines at a breakneck pace, but should investors add them to their portfolios in 2023? As the race to develop COVID-19 vaccines became paramount, Moderna's
Big Pharma's Big Gains
02:14am, Thursday, 09'th Feb 2023
Given enough time, stock in pharmaceutical giants has yielded life-altering gains. Because of its popular and widely distributed COVID-19 vaccine, Pfizer has sparked more controversy than other stocks
A Look at Pharma ETFs Post Q4 Earnings
03:05pm, Wednesday, 08'th Feb 2023 Zacks Investment Research
Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.
Deciphera's (DCPH) Q4 Earnings Miss, Qinlock Drives Revenues
01:43pm, Wednesday, 08'th Feb 2023 Zacks Investment Research
Deciphera (DCPH) reports a wider-than-expected loss per share for the fourth quarter of 2022, while revenues driven by Qinlock sales, beat estimates.
Pfizer: Time To Be Fearless
11:26am, Wednesday, 08'th Feb 2023
The significant drop of over 20% from December highs to last week's lows left PFE investors nursing their wounds. Pfizer's underwhelming FY23 outlook still fell short of downgraded analysts' estimates
Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
11:20am, Wednesday, 08'th Feb 2023 Zacks Investment Research
Smart Beta ETF report for PJP
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2023
03:00pm, Tuesday, 07'th Feb 2023 Benzinga
Upgrades
According to Raymond James, the prior rating for Kemper Corp (NYSE:KMPR) was changed from Outperform to Strong Buy. In the fourth quarter, Kemper showed an EPS of $0.41, compared to $2.05 fro
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
02:00pm, Tuesday, 07'th Feb 2023 Zacks Investment Research
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
This Healthcare Giant Expects Revenue to Crash More Than 30% This Year
11:30am, Tuesday, 07'th Feb 2023 The Motley Fool
Could Pfizer be a cheap contrarian stock to buy?
This Healthcare Giant Expects Revenue to Crash More Than 30% This Year
06:30am, Tuesday, 07'th Feb 2023
Could Pfizer be a cheap contrarian stock to buy?
3 Bargain Stocks to Snap Up Before the Crowd Gets Wise
07:54pm, Monday, 06'th Feb 2023
One of the best ways to make money in 2023 is by picking up red-hot bargain stocks in some of the hottest industries. Look at lithium stocks, like Albemarle (NYSE: ALB ), for example.
5 Stocks That Moved the Market in January
11:20am, Monday, 06'th Feb 2023 The Motley Fool
These stocks illustrate the most important trends in the stock market right now.
Is Gilead Sciences a Good Stock to Buy Now?
10:41am, Monday, 06'th Feb 2023 The Motley Fool
Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward.
Biogen: What To Do Ahead Of Q4 2022 Financial Report
07:12am, Monday, 06'th Feb 2023 Seeking Alpha
Biogen's business focuses on developing and commercializing drugs aimed at treating patients living with neurological and neurodegenerative diseases. Find out why BIIB stock is a Hold.
